Earnings & Reporting

As Harmony Biosciences presents at JPM, investors will scrutinize its strategy for sustaining growth beyond its star drug and advancing its rare disease pipeline.

Anterix hires a new product chief and sees its COO depart, signaling a major pivot from spectrum provider to a full-service solutions leader for utilities.

Evergy is repurchasing $244M of its convertible notes, a strategic play to reduce future stock dilution and manage complex arbitrage market ripples.

A new report shows consumers prioritizing savings over digital convenience, propelling regional chains like H-E-B past giants like Amazon and Costco.

A new forecast predicts a sluggish 1.3% national home price gain for 2026, masking a stark divide between resilient Northeast markets and cooling Sunbelt cities.

Tech giants Infosys and AWS are joining forces to accelerate generative AI adoption, promising to redefine software development and business operations globally.

With a year of record growth and major acquisitions, all eyes are on AHR's Q4 results to see if its strong momentum will carry into 2026.

In a major strategic shift, cybersecurity leader Coalfire appoints Google Cloud veteran Brad Little as CEO to drive growth in AI and cloud modernization.

Subsidiary Stand-By Golf reports a 22% profit jump, showcasing parent company TMGI's successful strategy in the booming, tech-driven golf market.

With a major new facility planned and a dynamic market, all eyes are on Clean Harbors as it prepares to address investors at two key January events.

STAAR Surgical stockholders rejected a lucrative Alcon merger, betting on the standalone potential of their EVO ICL lenses despite recent financial headwinds.

With its lead muscular dystrophy drug in late-stage trials, Edgewise Therapeutics heads to the JPM conference with high stakes for its pipeline and stock.

Fintech leader Broadridge completes its acquisition of Acolin, creating an end-to-end solution for asset managers in Europe's complex regulatory maze.

As Old National sets its earnings date, investors eye results from a transformative year marked by a major acquisition and strong regional performance.

Amid regulatory hurdles and a shifting housing market, AM Best analysts will offer key insights for the U.S. title insurance industry's future.

Following a period of mixed financials, Neogen appoints new leaders to drive innovation and growth in its critical global food safety division.

With a $257M war chest and a veteran team, BlossomHill will showcase its innovative pipeline for lung cancer and leukemia at the pivotal JPM conference.

EchoStar's soaring stock price has triggered a conversion option for its 2030 notes, creating a pivotal choice between debt, cash, and equity.

Fintech leader Inbank secures new capital to expand its car-as-a-service arm, Mobire, signaling strong investor belief in its embedded finance strategy.

Facing a 79% stock plunge, automotive tech firm MKDWELL repurchases shares worth 77% of its market cap in a bold display of confidence.